Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The role of the chemokine CXCL12 in osteoclastogenesis|
|Citation:||Trends in Endocrinology and Metabolism, 2007; 18(3):108-113|
|Publisher:||Elsevier Science London|
|Stan Gronthos and Andrew C.W. Zannettino|
|Abstract:||The chemokine CXCL12 (variously termed stromal-derived factor 1 or B cell-stimulating factor) is a highly conserved chemotactic cytokine belonging to the large family of CXC chemokines. CXCL12 has crucial roles in the formation of multiple organ systems during embryogenesis and in the regulation of bone marrow haematopoiesis and immune function in the postnatal organism. Although considered an important factor in normal bone metabolism, recent studies implicate CXCL12 in the pathogenesis of several diseases involving the skeleton, including rheumatoid arthritis and cancers that metastasize to bone. Recent studies have highlighted an emerging role for CXCL12 in the processes of physiological and pathological bone remodelling.|
|Keywords:||Osteoclasts; Animals; Humans; Bone Resorption; Chemokines, CXC; Bone Remodeling; Cell Differentiation; Models, Biological; Chemokine CXCL12|
|Rights:||© 2007 Elsevier Ltd. All rights reserved.|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.